FDA ephedrine proposal comment deadline extension urged by Reps. Boyd, Farr.
This article was originally published in The Tan Sheet
Executive Summary
FDA EPHEDRINE PROPOSAL COMMENT EXTENSION URGED BY REPS. BOYD, FARR in recent letters to the agency. Allen Boyd (D-Fla.) and Sam Farr (D-Calif.) support the allowance of additional time to facilitate public input to the proposed rule, which would establish serving limits and label warnings for dietary supplements containing ephedrine alkaloids ("The Tan Sheet" June 9, pp. 20-23). Rep. Boyd, a member of the House Small Business Committee, states in a Nov. 12 letter that "the management of this rule has made it difficult, if not impossible, for small businesses to participate in the rulemaking process."